• 1
    Chamberlain MC, Friedman HS. Leptomeningeal metastases. In: LevinVA, editor. Cancer in the nervous system. New York: Churchill Livingstone, 1996: 281301.
  • 2
    New PZ. Central nervous system emergencies. In: WeissGR, editor. Clinical oncology. Norwalk, CT: Appleton & Lange, 1993: 372379.
  • 3
    List J, Moser RP, Steuer M, London WG, Blacklock JB, Grimm EA. Cytokine responses to intraventricular injection of interleukin-2 into patients with leptomeningeal carcinomatosis: rapid induction of tumor necrosis factor alpha, interleukin-1-beta, interleukin-6, interferon, and soluble interleukin-2 receptor. Cancer Res. 1992; 52: 11231128.
  • 4
    Meyers CA, Yung WKA. Delayed neurotoxicity of intraventricular interleukin-2: a case report. J Neurooncol. 1993; 15: 265267.
  • 5
    Meyers CA, Valentine AD, Wong FCL, Leeds NE. Reversible neurotoxicity of interleukin-2 and tumor necrosis factor: correlations of SPECT with neuropsychological testing. J Neuropsychiatry Clin Neurosci. 1994; 6: 285288.
  • 6
    Fathallah-Shaykh HM, Zimmerman C, Morgan H, Rushing E, Schold SC, Unwin DH. Response of primary leptomeningeal melanoma to intrathecal recombinant interleukin-2. Cancer. 1996; 77: 15441550.
  • 7
    Mattis S. Dementia Rating Scale. Odessa, FL: Psychological Resources, Inc., 1988.
  • 8
    Hoffer SM, Piccinin AM, Hershey D. Analysis of structure and discriminative power of the Mattis Dementia Rating Scale. J Clin Psychiatry. 1996; 52: 395409.
  • 9
    Salmon DP, Yuen PFK, Heindel WC, Butters N, Thal LJ. Differentiation of Alzheimer's disease and Huntington's disease with the Dementia Rating Scale. Arch Neurol. 1989; 46: 12041208.
  • 10
    Rosser AE, Hodges JR. The Dementia Rating Scale in Alzheimer's disease, Huntington's disease and progressive supranuclear palsy. J Neurol. 1994; 241: 531536.
  • 11
    Paulsen JS, Butters N, Sadek JR, et al. Distinct cognitive profiles of cortical and subcortical dementia in advanced illness. Neurology. 1995; 45: 951956.
  • 12
    Medical Research Council Brain Tumour Working Party. Prognostic factors for high-grade malignant glioma: development of a prognostic index. J Neurooncol. 1990; 9: 4755.
  • 13
    Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12: 189198.
  • 14
    Meyers CA, Kudelka AP, Conrad CA, et al. Neurotoxicity of CI-980, a novel mitotic inhibitor. Clin Cancer Res. 1997; 3: 419422.
  • 15
    Siegel T, Mildworf B, Stein D, Melamed E. Leptomeningeal metastases: reduction in regional cerebral blood flow and cognitive impairment. Ann Neurol. 1985; 17: 100102.
  • 16
    Lezak MD. Neuropsychological assessment, 3rd ed. New York: Oxford University Press, 1995.